Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain AMGN message board posts where the ticker symbol AMGN has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest AMGN SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-023315 Size: 5 KB
2018-07-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000899243-18-018026 (34 Act)  Size: 9 KB
2018-06-25 001-38542
18918141
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0000899243-18-017437 (34 Act)  Size: 7 KB
2018-06-20 001-38542
18910463
11-K  Documents Annual report of employee stock purchase, savings and similar plans
Acc-no: 0000318154-18-000012 (34 Act)  Size: 4 MB
2018-06-18 001-37702
18905480
11-K  Documents Annual report of employee stock purchase, savings and similar plans
Acc-no: 0000318154-18-000011 (34 Act)  Size: 1 MB
2018-06-18 001-37702
18905453
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001127602-18-020733 Size: 5 KB
2018-06-12
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-005944 (34 Act)  Size: 14 KB
2018-05-30 000-12477
18867352
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001127602-18-018452 Size: 5 KB
2018-05-22
8-K  Documents Current report, items 5.07 and 9.01
Acc-no: 0001193125-18-170986 (34 Act)  Size: 58 KB
2018-05-22 001-37702
18853359
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-005783 (34 Act)  Size: 13 KB
2018-05-17 001-37702
18842655
More AMGN SEC Filings


Related news from
Mon, 16 Jul 2018
21:25:09 +0000
Pacira Focused on Exparel Development Amid Competition
Pacira (PCRX) focuses on the label expansion of its flagship product, Exparel.
Mon, 16 Jul 2018
12:31:12 +0000
Pfizer's Xtandi Gets FDA Nod for Expanded Patient Population
FDA approves Pfizer's (PFE) sNDA to expand the label of Xtandi to include the non-metastatic prostate cancer patient population.
Sun, 15 Jul 2018
12:00:00 +0000
Better Buy: Biogen Inc. vs. Amgen
Biogen and Amgen have been two of the best performing biotechs for a decade. But one stock clearly has an easier path toward value creation.
Sat, 14 Jul 2018
12:00:09 +0000
See what the IHS Markit Score report has to say about Amgen Inc.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting AMGN. Over the last one-month, outflows of investor capital in ETFs holding AMGN totaled $140 million.
Fri, 13 Jul 2018
14:15:00 +0000
Better Buy: Amgen Inc. vs. Johnson & Johnson
Which stock wins in a head-to-head match-up between these huge drugmakers?
Fri, 13 Jul 2018
12:51:12 +0000
Is the Options Market Predicting a Spike in Amgen (AMGN) Stock?
Investors need to pay close attention to Amgen (AMGN) stock based on the movements in the options market lately.
Fri, 13 Jul 2018
12:34:48 +0000
Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 12) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Arbutus Biopharma ...
Fri, 13 Jul 2018
12:16:00 +0000
2 Overlooked Biotech Stocks to Buy Now
The industry's biggest players just aren't getting the attention their cash flows deserve.
Fri, 13 Jul 2018
05:00:00 +0000
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY™ (romosozumab) To The US FDA
THOUSAND OAKS, Calif. and BRUSSELS, July 12, 2018 /PRNewswire/ -- Amgen (AMGN) and UCB (Euronext Brussels: UCB) today announced the resubmission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for EVENITY™* (romosozumab), an investigational monoclonal antibody for the treatment of osteoporosis in postmenopausal women at high risk for fracture. EVENITY increases bone formation and reduces bone resorption simultaneously to increase bone mineral density (BMD) and reduce the risk of fracture. "A fracture due to osteoporosis can be a life-altering event, and EVENITY has the potential to reduce fracture risk in patients at high risk due to a prior fracture," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen.
Thu, 12 Jul 2018
17:30:00 +0000
7 High-Margin Stocks Poised to Beat the Market
As the economy reaches the later stages of its cycle and profit growth slows, investors should take a look at Goldman Sachs’ basket of more than 30 Russell 1000 stocks with high gross profit margins that have proven stable over time. Seven of those stocks, which have been recent outperformers, include Verisign Inc. ( VRSN), Amgen Inc. ( AMGN), Cadence Design Systems Inc. ( CDNS), Adobe Systems Inc. ( ADBE), IDEXX Laboratories Inc. ( IDXX), Liberty Media Corp. ( LSXMA) and O’Reilly Automotive Inc. ( ORLY).
Wed, 11 Jul 2018
13:17:00 +0000
Your first trade for Wednesday, July 11
The "Fast Money" traders share their first moves for the market open.
Wed, 11 Jul 2018
13:15:00 +0000
3 Huge Biotech Winners in 2018 (So Far)
Why these stocks are the best biotech performers so far this year.
Tue, 10 Jul 2018
13:23:01 +0000
Moving Average Crossover Alert: Amgen (AMGN)
Amgen Inc. (AMGN) is looking like an interesting pick from a technical perspective
Mon, 09 Jul 2018
20:03:16 +0000
Incyte’s Valuations on July 6
According to Incyte Corporation (INCY), the firm is a “Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics.”
Mon, 09 Jul 2018
17:23:00 +0000
Bullish options traders target Amgen, this energy ETF
"Halftime Report" trader Pete Najarian and Mad Money's Jim Cramer discuss unusual options activity in Amgen and the XOP energy ETF.
Mon, 09 Jul 2018
12:00:00 +0000
Today's Research Reports on Stocks to Watch: Biogen and Amgen
Shares of Amgen also moved north as Wall Street's celebration of Biogen's news pushed many biotech stocks higher. Biogen Inc. shares were jumping on Friday, closing the day up almost 20% on high volume compared to usual. The company along with Eisai Co. Ltd. of Japan had announced positive results from an Alzheimer's study.
Fri, 06 Jul 2018
19:13:07 +0000
Why Biotech Stocks Rallied on Biogen's Alzheimer's Test
Several major biotech stocks rallied on Friday after Biogen (BIIB) reported positive results from a Phase 2 study of its Ban2401 therapy, which seeks to reduce toxic amyloid proteins associated with cognitive decline and Alzheimer's disease.
Fri, 06 Jul 2018
16:26:00 +0000
Biotech Stocks Rally on Biogen's Landmark Test
The NASDAQ Biotechnology Index rose about 3% in midday trading Friday to 3,636.45, the highest level since February. underperforming the overall NASDAQ Index in the past year, investors might be recognizing the hidden value of the firms' drug research and development, says Steve Chesney, an analyst for Atlantic Equities in London who covers large cap biotech firms worth more than $60 billion. Celgene, a biotechnology company which develops anti-inflammatory drugs for cancer and other diseases rose around 2% to $82.09 in early afternoon trading.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "VF is a great group of value seeking investors, who are most generous in sharing their research, news, business expertise, and investment experience. It is an invaluable resource, and brings many 'lessons learned' to the group." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards